Targeting Cytokine Signaling as an Innovative Therapeutic Approach for the Prevention of Atherosclerotic Plaque Development

被引:0
|
作者
Harald Schuett
Bernhard Schieffer
机构
[1] Hannover Medical School,Clinic for Cardiology and Angiology
来源
关键词
Tocilizumab; Coronary Artery Disease Patient; Innate Immune Defense; Experimental Mouse Model; Infection Susceptibility;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:187 / 189
页数:2
相关论文
共 50 条
  • [41] Ensuring successful development and introduction of multipurpose prevention technologies through an innovative partnership approach
    Holt, B. Young
    Romano, J.
    Manning, J.
    Hemmerling, A.
    Shields, W.
    Vyda, L.
    Lusti-Narasimhan, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 : 3 - 8
  • [42] Targeting SHP-1-STAT3 signaling: a promising therapeutic approach for the treatment of cholangiocarcinoma
    Hu, M. H.
    Chen, L. J.
    Chen, Y. L.
    Tsai, M. S.
    Shiau, C. W.
    Chao, T. I.
    Kao, J. H.
    Chen, K. F.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S86 - S86
  • [43] Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma
    Hu, Ming-Hung
    Chen, Li-Ju
    Chen, Yen-Lin
    Tsai, Ming-Shen
    Shiau, Chung-Wai
    Chao, Tzu-I
    Liu, Chun-Yu
    Kao, Jia-Horng
    Chen, Kuen-Feng
    ONCOTARGET, 2017, 8 (39) : 65077 - 65089
  • [44] TARGETING CGAS-STING SIGNALING: A POTENTIAL THERAPEUTIC APPROACH FOR THE MANAGEMENT OF HUNTINGTON'S DISEASE
    Kumar, Vishal
    Kumar, Puneet
    EXCLI JOURNAL, 2025, 24 : 201 - 203
  • [45] The Use of Aspirin in Contemporary Primary Prevention of Atherosclerotic Cardiovascular Diseases Revisited: The Increasing Need and Call for a Personalized Therapeutic Approach
    Fras, Zlatko
    Sahebkar, Amirhossein
    Banach, Maciej
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (02) : 139 - 151
  • [46] The Use of Aspirin in Contemporary Primary Prevention of Atherosclerotic Cardiovascular Diseases Revisited: The Increasing Need and Call for a Personalized Therapeutic Approach
    Zlatko Fras
    Amirhossein Sahebkar
    Maciej Banach
    American Journal of Cardiovascular Drugs, 2021, 21 : 139 - 151
  • [47] A novel therapeutic approach for esophageal squamous cell carcinoma: suppressor of cytokine signaling-1 gene therapy
    Chen, Chang-Han
    Li, Shau-Hsuan
    JOURNAL OF THORACIC DISEASE, 2017, 9 (06) : 1446 - 1449
  • [48] Targeting of free fatty acid signaling in ovarian cancer may serve as a potential therapeutic approach.
    Munkarah, Adnan
    Hamid, Suhail
    Chhina, Jasdeep
    Mert, Ismail
    Jackson, LaToya
    Hensley-Alford, Sharon
    Chitale, Dhananjay
    Giri, Shailendra
    Rattan, Ramandeep
    CLINICAL CANCER RESEARCH, 2016, 22
  • [49] Targeting β2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma
    Nomura, Takeo
    Huang, Wen-Chin
    Seo, Seongil
    Zhau, Haiyen E.
    Mimata, Hiromitsu
    Chung, Leland W. K.
    JOURNAL OF UROLOGY, 2007, 178 (01): : 292 - 300
  • [50] Targeting YAP/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma
    Sato, Kuniaki
    Faraji, Farhoud
    Cervantes-Villagrana, Rodolfo Daniel
    Wu, Xingyu
    Koshizuka, Keiichi
    Ishikawa, Tomohiko
    Iglesias-Bartolome, Ramiro
    Chen, Lei
    de Marval, Paula L. Miliani
    Gwaltney, Stephen L.
    Adler, Benjamin
    Gutkind, J. Silvio
    CANCER LETTERS, 2025, 612